No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...

Fibrobiologics' cell therapy CYMS101 significantly increased myelin production and promoted myelin repair in a mouse model of MS ...

The patient support program Cycle Vita will be available for people with MS taking Bafiertam (monomethyl fumarate) starting ...

Columnist Desiree Lama remembers how a best friend helped her with stressful assignments and RRMS symptoms in college.

MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...

A small molecule that blocks TYK2 in the brain showed promise for reducing disease activity in mouse models of multiple ...

Fooling others — and himself — into believing his MS symptoms weren't a big deal wasn't a good approach, writes columnist Be.

Sexual dysfunction was found to affect 80% of Iranian women with MS, with older age and lower education levels being key ...

The AdventHealth Neuroscience Institute is testing IDP-023 for primary or nonactive secondary progressive multiple sclerosis ...

Anne Rosales, living with MS, shares how partnering with your medical team empowers you to take charge of your health.

Treatment with high-dose vitamin D reduced disease activity in people with clinically isolated syndrome in a Phase 3 trial.

Barry Singer, MD, explains why setting realistic expectations about MS treatments is key to managing the disease effectively.